caret

Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

01 Sep 2023

CEPI and IVI renew partnership to accelerate development of vaccines against emerging infectious disease threats
IVI will provide technical services for CEPI-funded projects, leveraging IVI’s expertise and capabilities

Read more

Read article

29 Aug 2023

CEPI and University of Oxford to accelerate vaccine development against Disease X 
CEPI pledges $80 million to support development of vaccines against outbreak threats, partnering with the University of Oxford to harness their expertise for rapid pandemic response through adaptable ChAdOx technology

Read more

29 Aug 2023

Partnering to deliver the 100 Days Mission
Explore CEPI's dynamic partnerships for global pandemic readiness. Uniting equity and innovation, our collaborations drive rapid pandemic response. See how we're boosting preparedness with agile partnerships like the University of Oxford.

Read more

23 Aug 2023

Clinical trials in remote rainforests: how vital Ebola research in DRC enhances local expertise and infrastructure
Prof. Hypolite Muhindo-Mavoko talks about the challenges and rewards that come with conducting vaccine trials for deadly viruses in the isolated city of Boende

Read more

08 Aug 2023

CEPI to support development of self-amplifying mRNA vaccine technology for use against Disease X
CEPI to provide funding of up to US$3.6 million, which will support optimisation of the technology platform to enhance immunogenicity.

Read more

18 Jul 2023

Using AI to speed up vaccine development against Disease X
CEPI partners with Houston Medical Research Institute to use artificial intelligence for design of vaccines to fight diseases with pandemic potential

Read more

05 Jul 2023

What are monoclonal antibodies, and what role could they play in ending a potential pandemic?
Monoclonal antibodies could play an important complementary role, alongside vaccines, in helping to end future epidemic and pandemic threats.

Read more

27 Jun 2023

CEPI partners with RVAC Medicines to accelerate manufacturing of mRNA vaccines
Funding of up to US$3 million aims to accelerate the manufacturing process for RVAC's mRNA vaccine platform technology

Read more

Read article

26 Jun 2023

SCARDA and CEPI collaborate to strengthen global pandemic preparedness and response
Memorandum of Cooperation will enable sharing of expertise, knowledge and experience between the two organizations

Read more

22 Jun 2023

Licenced Chikungunya vaccines are on the horizon
Enabling access to them in endemic countries will be crucial to combatting this debilitating disease

Read more

22 Jun 2023

Using “human challenge” studies in the hunt for virus-blocking vaccines
Fighting epidemics and pandemics is possible with disease-reducing vaccines, but it would be faster and more effective if we also had vaccines that can stop viral spread.

Read more

©2023 CEPI. All rights reserved